News | December 09, 2009

Dose Escalation Achieved, Sparing Healthy Tissue

December 10, 2009 - Better dose conformality can be reached with intensity-modulated radiotherapy (IMRT) in comparison to three-dimensional conformal radiotherapy techniques - as used in dose escalation studies - offering an additional opportunity for healthy tissue protection, reports Michael Pinkawa, M.D., in an abstract of his study published in UroToday.com.

The study's objective is to compare the dose distribution in IMRT treatment plans with and without a simultaneous integrated boost (IB) after performing a PET/CT with 18F-choline for treatment planning. Dose-volume histograms and equivalent uniform doses (EUD) were evaluated and normal tissue complication probability (NTCP) for the bladder and rectum compared.

Dr. Pinkawa found that while improved biochemical control rates for prostate cancer have been consistently shown in randomized three-dimensional (3D) conformal radiotherapy dose escalation studies, this benefit was associated with the problem of increased rectal toxicity. The increasing implementation of image-guided radiotherapy (IGRT) allows a reduction of safety margins around the clinical target volume (CTV). Thus, the same or improved local tumor control with lower rectal toxicity due to reduced rectal volume within the target volume can be expected.

Dr. Pinkawa also points to dose-painting as another advantage associated with IMRT as areas with a higher risk of tumor recurrence or a higher tumor load can be covered with larger doses in the same fraction. In view of an often multifocal micrsoscopic spread of prostate cancer - not possible to delineate with the presently available imaging modalities - the whole prostate must still be covered by an effective dose.

He found that treatment planning with a simultaneous integrated boost allows an individually adapted dose escalation. The boost volume, as defined by a tumor-to-background uptake ratio >2 in a PET/CT with choline, correlated with several well-established prognostic parameters. His founding indicated that the therapeutic ratio can be improved by a considerable dose escalation to the macroscopic tumor site without considerably increasing the NTCP for the rectum and bladder.

For more information: www.urotoday.com

Related Content

Immune Inflammatory Levels Linked to Disease-Free Survival in Prostate Cancer
News | Prostate Cancer | November 19, 2018
Data from a validation study of a high-risk prostate cancer trial suggests that higher levels of pretreatment...
Merit Medical Completes Acquisition of Cianna Medical
News | Women's Health | November 14, 2018
Disposable device manufacturer Merit Medical Systems Inc. announced the closing of a definitive merger agreement to...
Videos | ASTRO | November 08, 2018
ITN Editor Dave Fornell took a tour of some of the most innovative technologies on display on the expo floor at the 
The Fujifilm FCT Embrace CT System displayed for the first time at ASTRO 2018.
360 Photos | 360 View Photos | November 07, 2018
Fujifilm's first FDA-cleared compu...
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for radiation therapy displayed for the first time since gaining FDA clearance in 2018. It was displayed at the American Society for Radiotherapy and Oncology (ASTRO) 2018 annual meeting. Read more about this system at ASTRO 2018. #ASTRO18 #ASTRO2018
360 Photos | 360 View Photos | November 07, 2018
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for...
GE Healthcare Discovery RF Gen 2 system displayed at ASTRO 2018. It is a dedicated computed tomography (CT) scanner for radiation oncology
360 Photos | 360 View Photos | November 07, 2018
This is the GE Healthcare Discovery RF Gen 2 system displayed at the ...
Proton Therapy for Pediatric Brain Tumors Has Favorable Cognitive Outcomes
News | Proton Therapy | November 06, 2018
Proton therapy treatment for pediatric brain tumor patients is associated with better neurocognitive outcomes compared...
Videos | Radiation Oncology | November 06, 2018
Genomics can be used to assess a patient's radiosensitivity, which can be used to increase or decrease the radiation